IHC staining of combinations of biomarkers of Eag1, p16 and Ki-67 may help us to improve the ability to identify risk groups with abnormal follow-up outcomes after treatment for CIN. The gene discussed is MKI67; the disease is cervical squamous intraepithelial neoplasia.